BIOMAT Database Logo BIOMAT Database Logo

Effect of pancreas transplantation on lipoprotein lipase, postprandial lipemia, and HDL cholesterol. 1994

B Föger, and A Königsrainer, and G Palos, and E Brandstätter, and A Ritsch, and P König, and G Miesenböck, and M Lechleitner, and R Margreiter, and J R Patsch
Department of Medicine, University of Innsbruck, Austria.

Pancreas transplantation with systemic venous drainage of the graft causes elevated plasma levels of insulin, known to be a potent regulator of plasma lipoprotein metabolism. We studied 11 post-type I diabetic pancreas-kidney transplant recipients, 9 type I diabetic kidney transplant recipients displaying peripheral hyperinsulinemia due to subcutaneous insulin treatment, 11 nondiabetic kidney transplant recipients as controls for the effects of immunosuppressive medication, and 11 healthy control subjects, all matched for age, sex, and body mass index. We determined fasting lipids, lipoproteins and lipolytic enzymes, as well as postprandial lipid metabolism after a standardized oral fat load. High-density lipoprotein (HDL) cholesterol averaged 1.98 (0.40) mmol/L in pancreas-kidney transplant patients, clearly higher than that of kidney transplant recipients (1.52 (0.36) mmol/L, P < 0.05) or of controls (1.50 (0.38) mmol/L, P < 0.05). In pancreas-kidney transplant patients postprandial lipemia was lowest and lipoprotein lipase activity was highest (average 32% and 154%, respectively, of the mean of the controls) compared with nondiabetic kidney transplant recipients (P < 0.005, P < 0.05) and healthy controls (P < 0.001, P < 0.01). In type I diabetic kidney transplant recipients the levels of HDL cholesterol (1.88 (0.63) mmol/L), postprandial lipemia, and lipoprotein lipase activity were intermediate between pancreas-kidney transplant patients and healthy controls. The distinctly elevated HDL cholesterol in pancreas-kidney transplant patients can be readily explained by the low postprandial triglyceride levels resulting from a high activity of lipoprotein lipase. The very favorable lipid profile in post-diabetic pancreas-kidney transplant recipients could be expected to counteract the severe atherosclerotic risk of long-standing diabetes.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008071 Lipoprotein Lipase An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. The enzyme hydrolyzes triacylglycerols in chylomicrons, very-low-density lipoproteins, low-density lipoproteins, and diacylglycerols. It occurs on capillary endothelial surfaces, especially in mammary, muscle, and adipose tissue. Genetic deficiency of the enzyme causes familial hyperlipoproteinemia Type I. (Dorland, 27th ed) EC 3.1.1.34. Heparin-Clearing Factor,Lipemia-Clearing Factor,Diacylglycerol Lipase,Diglyceride Lipase,Post-Heparin Lipase,Postheparin Lipase,Postheparin Lipoprotein Lipase,Factor, Heparin-Clearing,Factor, Lipemia-Clearing,Heparin Clearing Factor,Lipase, Diacylglycerol,Lipase, Diglyceride,Lipase, Lipoprotein,Lipase, Post-Heparin,Lipase, Postheparin,Lipase, Postheparin Lipoprotein,Lipemia Clearing Factor,Lipoprotein Lipase, Postheparin,Post Heparin Lipase
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008297 Male Males
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

B Föger, and A Königsrainer, and G Palos, and E Brandstätter, and A Ritsch, and P König, and G Miesenböck, and M Lechleitner, and R Margreiter, and J R Patsch
Effect of exercise timing on postprandial lipemia and HDL cholesterol subfractions.
October 1998, Journal of applied physiology (Bethesda, Md. : 1985),
B Föger, and A Königsrainer, and G Palos, and E Brandstätter, and A Ritsch, and P König, and G Miesenböck, and M Lechleitner, and R Margreiter, and J R Patsch
Moderate exercise, postprandial lipemia, and skeletal muscle lipoprotein lipase activity.
July 2001, Metabolism: clinical and experimental,
B Föger, and A Königsrainer, and G Palos, and E Brandstätter, and A Ritsch, and P König, and G Miesenböck, and M Lechleitner, and R Margreiter, and J R Patsch
Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia.
March 1995, Arteriosclerosis, thrombosis, and vascular biology,
B Föger, and A Königsrainer, and G Palos, and E Brandstätter, and A Ritsch, and P König, and G Miesenböck, and M Lechleitner, and R Margreiter, and J R Patsch
High density lipoproteins in postprandial lipemia. Relation to sex and lipoprotein lipase activity.
February 1986, Atherosclerosis,
B Föger, and A Königsrainer, and G Palos, and E Brandstätter, and A Ritsch, and P König, and G Miesenböck, and M Lechleitner, and R Margreiter, and J R Patsch
Postprandial lipemia and reverse cholesterol transport.
September 1990, Nutrition reviews,
B Föger, and A Königsrainer, and G Palos, and E Brandstätter, and A Ritsch, and P König, and G Miesenböck, and M Lechleitner, and R Margreiter, and J R Patsch
[EFFECT OF ALIMENTARY LIPEMIA ON ACTIVATION OF LIPOPROTEIN LIPASE AND POSTHEPARIN ESTERASE].
January 1963, Acta Universitatis Carolinae. Medica,
B Föger, and A Königsrainer, and G Palos, and E Brandstätter, and A Ritsch, and P König, and G Miesenböck, and M Lechleitner, and R Margreiter, and J R Patsch
Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosis.
January 2003, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique,
B Föger, and A Königsrainer, and G Palos, and E Brandstätter, and A Ritsch, and P König, and G Miesenböck, and M Lechleitner, and R Margreiter, and J R Patsch
Effects of postprandial lipemia on plasma cholesterol metabolism.
March 1985, The Journal of clinical investigation,
B Föger, and A Königsrainer, and G Palos, and E Brandstätter, and A Ritsch, and P König, and G Miesenböck, and M Lechleitner, and R Margreiter, and J R Patsch
Postprandial lipemia in postmenopausal women with high fasting high-density lipoprotein cholesterol.
January 2006, The American journal of the medical sciences,
B Föger, and A Königsrainer, and G Palos, and E Brandstätter, and A Ritsch, and P König, and G Miesenböck, and M Lechleitner, and R Margreiter, and J R Patsch
High density lipoproteins with differing apolipoproteins: relationships to postprandial lipemia, cholesteryl ester transfer protein, and activities of lipoprotein lipase, hepatic lipase, and lecithin: cholesterol acyltransferase.
February 1994, Journal of lipid research,
Copied contents to your clipboard!